In the present study, we found that CB2R KO contributed to the pathogenesis of psoriasis by promoting CD4+ T cell proliferation; upregulating Th17 cytokines, such as IL-17A, IL-23A, and IL-17C; and downregulating IL-10. Here, CD4 is linked to psoriasis.